Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 7529

BillFederalHouseIn Committee
To require direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information.
About This Bill
Committee
Latest Action · April 15, 2022
Referred to the Subcommittee on Health.
Congress
117th (2021–2023)
Introduced
April 14, 2022
Cosponsors (3)
1D 2R
View PDF ↗

Summary

Highlight any text to annotate
Plain Prescription Prices Act This bill requires the Centers for Medicare & Medicaid Services to issue a rule requiring direct-to-consumer television advertisements for prescription drugs that are covered by Medicare or Medicaid to include a textual statement of the drug's list price.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.